SMTL ID : 5etu.2 (1 other biounit)

Cetuximab Fab in complex with L5E meditope variant

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.53 Å

Oligo State

hetero-1-1-1-mer

Ligands

3 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.1: 4 residues within 4Å: Chain A: E.165, D.167 Chain B: V.169, H.170 5 PLIP interactions: 2 interactions with chain B, 3 interactions with chain A Water bridges: B:V.169, A:T.164, A:E.165, A:S.168 Salt bridges: B:H.170 PO4.2: 2 residues within 4Å: Chain A: R.108, T.109 2 PLIP interactions: 2 interactions with chain A Water bridges: A:R.108 Salt bridges: A:R.108 PO4.3: 4 residues within 4Å: Chain B: N.205, K.207, N.210, K.212 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:N.205, B:N.205, B:N.210 Salt bridges: B:K.212

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bzymek, K.P. et al., Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun (2016)

Release Date

2016-10-26

Peptides

Cetuximab Fab light chain: A
Cetuximab Fab heavy chain: B
L5E meditope variant: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

C
F

Cetuximab Fab light chain

Cetuximab Fab heavy chain

L5E meditope variant

Related Entries With Identical Sequence